Xiangwei Ge

621 total citations
23 papers, 403 citations indexed

About

Xiangwei Ge is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiangwei Ge has authored 23 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Xiangwei Ge's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Xiangwei Ge is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Xiangwei Ge collaborates with scholars based in China, United States and United Kingdom. Xiangwei Ge's co-authors include Lin‐Feng Yan, Guangbin Cui, Yu Han, Wen Wang, Yu‐Chuan Hu, Songlin Yan, Bo Hu, Jin Zhang, Hai‐Yan Nan and Xin Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiangwei Ge

18 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangwei Ge China 8 140 120 106 100 100 23 403
Gang Xiao China 12 61 0.4× 325 2.7× 121 1.1× 123 1.2× 33 0.3× 29 564
Chuandong Cheng China 13 49 0.3× 59 0.5× 95 0.9× 58 0.6× 45 0.5× 23 604
Zeyan Xu China 13 109 0.8× 440 3.7× 180 1.7× 91 0.9× 149 1.5× 42 758
Abudumijiti Aibaidula China 12 47 0.3× 197 1.6× 39 0.4× 69 0.7× 27 0.3× 22 459
Luu Ho Thanh Lam Taiwan 8 27 0.2× 134 1.1× 44 0.4× 66 0.7× 18 0.2× 9 365
Ritesh Parajuli United States 11 38 0.3× 190 1.6× 195 1.8× 55 0.6× 19 0.2× 27 529
Béatrice Carsin France 8 41 0.3× 142 1.2× 24 0.2× 34 0.3× 70 0.7× 9 305
Laura Roccograndi United States 5 50 0.4× 175 1.5× 58 0.5× 37 0.4× 13 0.1× 11 401
Yajie Hu China 9 32 0.2× 106 0.9× 190 1.8× 148 1.5× 54 0.5× 26 468

Countries citing papers authored by Xiangwei Ge

Since Specialization
Citations

This map shows the geographic impact of Xiangwei Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangwei Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangwei Ge more than expected).

Fields of papers citing papers by Xiangwei Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangwei Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangwei Ge. The network helps show where Xiangwei Ge may publish in the future.

Co-authorship network of co-authors of Xiangwei Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangwei Ge. A scholar is included among the top collaborators of Xiangwei Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangwei Ge. Xiangwei Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Xiangwei, et al.. (2025). PD-1/PD-L1 inhibitors monotherapy vs. combination therapy in elderly advanced NSCLC: a real-world study and nomogram for survival prognosis. BMC Pulmonary Medicine. 25(1). 350–350. 1 indexed citations
2.
Zhang, D. H., Jing Lin, Qiwei Jiang, et al.. (2025). Glutamine binds HSC70 to transduce signals inhibiting IFN-β-mediated immunogenic cell death. Developmental Cell. 60(14). 1958–1973.e9. 1 indexed citations
3.
Duan, Wentao, et al.. (2024). A Review of Cross-Age Facial Recognition Based on Discriminative Models. Lecture notes in computer science. 262–273.
4.
5.
Ge, Xiangwei, Hao Fan, Hongyang Yu, et al.. (2024). STING facilitates the development of radiation-induced lung injury via regulating the PERK/eIF2α pathway. Translational Lung Cancer Research. 13(11). 3010–3025. 3 indexed citations
6.
7.
8.
9.
10.
Ge, Xiangwei, Deyu Zhang, Yue Mi, et al.. (2022). USP18 reduces paclitaxol sensitivity of triple-negative breast cancer via autophagy. Biochemical and Biophysical Research Communications. 599. 120–126. 7 indexed citations
11.
Lu, Di, Zhiqiang Ma, Di Huang, et al.. (2022). Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study. Translational Lung Cancer Research. 11(6). 1119–1131. 5 indexed citations
12.
Ge, Xiangwei, Qiwei Jiang, Tian Xie, et al.. (2022). [Eukaryotic expression of human Y-box binding protein 1 (YB-1) promotes the proliferation and migration of human HepG2 cells].. PubMed. 38(11). 986–991. 1 indexed citations
13.
Wang, Jinliang, Zhibo Zhang, Yan Xiang, et al.. (2022). Using multiomics analysis to examine prognostic biomarkers for patients with squamous cell lung carcinoma treated with neoadjuvant therapy of camrelizumab combined with Apatinib.. Journal of Clinical Oncology. 40(16_suppl). e20563–e20563.
14.
Wang, Liang, Xiangwei Ge, Zifeng Zhang, et al.. (2021). Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma. Frontiers in Genetics. 12. 682082–682082. 20 indexed citations
15.
Zhang, Deyu, Qiwei Jiang, Xiangwei Ge, et al.. (2021). RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway. International Journal of Biological Sciences. 17(10). 2622–2632. 46 indexed citations
16.
17.
Zhang, Zhibo, Yuan Fang, Runzhe Chen, et al.. (2020). Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors. Frontiers in Immunology. 11. 1173–1173. 33 indexed citations
18.
Ge, Xiangwei, Zhibo Zhang, Sujie Zhang, et al.. (2020). Immunotherapy beyond progression in patients with advanced non-small cell lung cancer. Translational Lung Cancer Research. 9(6). 2391–2400. 27 indexed citations
19.
Ge, Xiangwei, et al.. (2020). [Research Progress of Circular RNA in Lung Cancer].. SHILAP Revista de lepidopterología. 23(12). 1095–1100. 1 indexed citations
20.
Yang, Yang, Lin‐Feng Yan, Xin Zhang, et al.. (2018). Glioma Grading on Conventional MR Images: A Deep Learning Study With Transfer Learning. Frontiers in Neuroscience. 12. 804–804. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gang Xiao Breakdown of academic impact, for papers by Chuandong Cheng Breakdown of academic impact, for papers by Zeyan Xu Breakdown of academic impact, for papers by Abudumijiti Aibaidula Breakdown of academic impact, for papers by Luu Ho Thanh Lam Breakdown of academic impact, for papers by Ritesh Parajuli Breakdown of academic impact, for papers by Béatrice Carsin Breakdown of academic impact, for papers by Laura Roccograndi Breakdown of academic impact, for papers by Yajie Hu
Rankless by CCL
2026